<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE book-part-wrapper PUBLIC "-//NLM//DTD BITS Book Interchange DTD v2.0 20151225//EN" "http://jats.nlm.nih.gov/extensions/bits/2.0/BITS-book2.dtd">
<book-part-wrapper id="article-30100" content-type="chapter" dtd-version="2.0">
  <book-meta>
    <book-id book-id-type="pmcid">statpearls</book-id>
    <book-title-group>
      <book-title>StatPearls</book-title>
    </book-title-group>
    <pub-date publication-format="electronic" date-type="pubr">
      <month>01</month>
      <year>2024</year>
    </pub-date>
    <publisher>
      <publisher-name>StatPearls Publishing</publisher-name>
      <publisher-loc>Treasure Island (FL)</publisher-loc>
    </publisher>
    <permissions>
      <copyright-statement>Copyright &#x000a9; 2024, StatPearls Publishing LLC</copyright-statement>
      <license xmlns:xlink="http://www.w3.org/1999/xlink" license-type="open-access" xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/">
        <license-p>
This book is distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0)
(<ext-link xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/" ext-link-type="uri">
http://creativecommons.org/licenses/by-nc-nd/4.0/
</ext-link>), which permits others to distribute the work, provided that the article is not altered or used commercially. You are not required to obtain permission to distribute this article, provided that you credit the author and journal.
</license-p>
      </license>
    </permissions>
    <custom-meta-group>
      <custom-meta>
        <meta-name>books-source-type</meta-name>
        <meta-value>Database</meta-value>
      </custom-meta>
    </custom-meta-group>
    <notes notes-type="disclaimer">
      <p>The intent of StatPearls review books and articles is to identify knowledge deficits and assist you in the learning process. Review books and articles are not intended to be a source of the knowledge base of medicine. The authors and editors do not warrant the information is complete or accurate. The reader is encouraged to verify content and questions in several references. All drug indications and dosages should be verified before administration.</p>
      <p>The authors and editors would like to extend special thanks to Erin Hughes and Gerson Rubio for their editorial support.</p>
    </notes>
  </book-meta>
  <book-part book-part-type="chapter">
    <book-part-meta>
      <title-group>
        <title>Secondary Thrombocytosis</title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Rokkam</surname>
            <given-names>Venkata R.</given-names>
          </name>
          <aff>Banner University</aff>
        </contrib>
      </contrib-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Killeen</surname>
            <given-names>Robert B.</given-names>
          </name>
          <aff>University of Illinois</aff>
        </contrib>
      </contrib-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Kotagiri</surname>
            <given-names>Rajesh</given-names>
          </name>
          <aff>Banner University Medical Center, Tucson</aff>
        </contrib>
      </contrib-group>
      <author-notes>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Venkata Rokkam declares no relevant financial relationships with ineligible companies.</p>
        </fn>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Robert Killeen declares no relevant financial relationships with ineligible companies.</p>
        </fn>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Rajesh Kotagiri declares no relevant financial relationships with ineligible companies.</p>
        </fn>
      </author-notes>
      <pub-history>
        <date date-type="updated">
          <day>6</day>
          <month>8</month>
          <year>2024</year>
        </date>
      </pub-history>
    </book-part-meta>
    <body>
      <sec id="article-30100.s1" sec-type="Continuing Education Activity">
        <title>Continuing Education Activity</title>
        <p>Thrombocytosis, or thrombocythemia, occurs when the platelet count exceeds 450,000/&#x003bc;L of blood. This condition can be classified into primary and secondary thrombocytosis. Secondary thrombocytosis, also known as reactive thrombocytosis, is characterized by an abnormally high platelet count in the absence of chronic myeloproliferative disease due to underlying conditions, infections or diseases, inflammation, hemorrhage, or certain medications.&#x000a0;Secondary thrombocytosis, which is more common than primary thrombocytosis, is typically identified through routine laboratory testing, as most patients are asymptomatic.&#x000a0;In most cases, reactive thrombocytosis symptoms are due to the underlying disorder rather than the elevated platelet count itself. Rarely, extreme secondary thrombocytosis may lead to thrombotic events such as acute myocardial infarction, mesenteric vein thrombosis, and pulmonary embolism. Although secondary thrombocytosis is generally benign, the underlying causes (such as malignancies, connective tissue disorders, and chronic infections) can increase the risk of adverse outcomes.</p>
        <p>Diagnosis involves a complete blood count revealing a platelet count above 450,000/&#x003bc;L and additional tests to differentiate it from primary thrombocytosis, including peripheral blood smears, inflammatory markers (such as erythrocyte sedimentation rate and C-reactive protein), and iron studies. Treatment focuses on addressing the underlying cause, which typically resolves the elevated platelet count. Antiplatelet therapy is generally unnecessary unless the platelet count is extremely high or there is a risk of thrombosis.&#x000a0;This activity reviews the etiology, diagnostic strategies, and treatment options for managing secondary thrombocytosis and provides healthcare professionals with the necessary tools and skills to address the complexities of elevated platelet levels associated with underlying medical conditions. This activity also fosters collaboration among multidisciplinary healthcare professionals and aims to improve patient care and outcomes.</p>
        <p>
<bold>Objectives:</bold>
<list list-type="bullet"><list-item><p>Identify the clinical indications and underlying etiologies of secondary thrombocytosis.</p></list-item><list-item><p>Implement appropriate treatment strategies to address the root cause of secondary thrombocytosis based on individual patient presentations.</p></list-item><list-item><p>Evaluate patients with secondary thrombocytosis and assess if further diagnostic studies are indicated.</p></list-item><list-item><p>Collaborate with a multidisciplinary healthcare team to provide comprehensive care for patients with secondary thrombocytosis.</p></list-item></list>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=30100&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=30100">Access free multiple choice questions on this topic.</ext-link>
</p>
      </sec>
      <sec id="article-30100.s2" sec-type="pubmed-excerpt">
        <title>Introduction</title>
        <p>Once referred to ignobly as "blood dust," platelets are a component of blood&#x000a0;produced in the bone marrow that have a vital role in the blood clotting process.<xref ref-type="bibr" rid="article-30100.r1">[1]</xref>&#x000a0;The average platelet count in adults and children is usually between&#x000a0;150,000&#x000a0;and 450,000/&#x003bc;L (150 to 450 x 10/L), although the normal range may vary in different clinical laboratories. Thrombocytosis,&#x000a0;or thrombocythemia, occurs when the platelet count exceeds 450,000/&#x003bc;L of blood.<xref ref-type="bibr" rid="article-30100.r2">[2]</xref>&#x000a0;</p>
        <p>Thrombocytosis can be classified into primary and secondary (or reactive) thrombocytosis.<xref ref-type="bibr" rid="article-30100.r3">[3]</xref>&#x000a0;This&#x000a0;distinction is essential as it carries implications for evaluation, prognosis, and treatment. Primary thrombocytosis results from an unregulated abnormality in platelet production by bone marrow progenitor cells and is usually associated with myeloproliferative neoplasms.<xref ref-type="bibr" rid="article-30100.r4">[4]</xref>&#x000a0;Primary&#x000a0;thrombocytosis, especially in conditions such as essential thrombocythemia and polycythemia vera, carries an increased risk of thrombosis and bleeding compared to secondary thrombocytosis.<xref ref-type="bibr" rid="article-30100.r5">[5]</xref></p>
        <p>Secondary&#x000a0;thrombocytosis, also known as reactive thrombocytosis, is characterized by an abnormally high platelet count due to underlying events, infections or diseases, or certain medications.&#x000a0;Secondary&#x000a0;thrombocytosis, which is more common than primary thrombocytosis, is typically identified through routine laboratory studies. In most cases, secondary thrombocytosis symptoms are due to an underlying disorder rather than the thrombocytosis itself. Rarely, extreme thrombocytosis may lead to thrombotic events such as acute myocardial infarction, mesenteric vein thrombosis, and pulmonary embolism.<xref ref-type="bibr" rid="article-30100.r6">[6]</xref>&#x000a0;</p>
        <p>Although secondary thrombocytosis is typically benign, the underlying causes&#x02014;such as malignancy, connective tissue disorders, and chronic infections&#x02014;can be associated with an increased risk of adverse outcomes. Approximately 80% to 90% of individuals with thrombocytosis are known to have secondary thrombocytosis.<xref ref-type="bibr" rid="article-30100.r7">[7]</xref>&#x000a0;Causes of secondary thrombocytosis include transient conditions like acute blood loss or infection, as well as sustained factors such as iron deficiency, asplenia, cancer, chronic inflammation, or infectious diseases. Reactive thrombocytosis is a laboratory anomaly that generally resolves once the underlying causative condition is addressed.</p>
      </sec>
      <sec id="article-30100.s3" sec-type="Etiology">
        <title>Etiology</title>
        <p>The common factor among the various underlying causes of secondary thrombocytosis is the presence of inflammatory compounds, such as interleukin 6 (IL6), which enhance thrombopoietin secretion and subsequently increase megakaryocyte production.<xref ref-type="bibr" rid="article-30100.r8">[8]</xref>&#x000a0;Secondary&#x000a0;thrombocytosis etiologies are often categorized under the "5 I's"&#x02014;inflammation, ischemia, infection, infarction, and iron deficiency.&#x000a0;</p>
        <p>
<bold>Infection</bold>
</p>
        <p>Acute bacterial, viral, or chronic infectious conditions (eg, tuberculosis) can cause secondary thrombocytosis due to increased production of IL6&#x02014;an inflammatory component that enhances thrombopoietin synthesis. Approximately 75% of pediatric patients with reactive thrombocytosis have an infectious etiology.<xref ref-type="bibr" rid="article-30100.r9">[9]</xref>&#x000a0;Clinical features associated with reactive thrombocytosis include fever, tachycardia, weight loss, hypoalbuminemia, leucocytosis, and anemia. Secondary thrombocytosis is less common in COVID-19 and is considered a poor prognostic sign; instead, thrombocytopenia typically occurs secondary due to a direct effect of antibodies or immune complexes on megakaryocytes in the bone marrow.<xref ref-type="bibr" rid="article-30100.r10">[10]</xref>&#x000a0;During a COVID-19 infection, a hyperinflammatory cytokine storm releases large amounts of inflammatory compounds (eg, IL1B, IL12, interferon (IFN)-gamma, and IL6). IL6 causes prominent thrombopoiesis through its stimulatory effect on thrombopoietin, subsequently increasing megakaryocyte proliferation.&#x000a0;</p>
        <p>
<bold>Functional and Surgical Asplenia</bold>
</p>
        <p>The major functions of the spleen are immune activity and blood filtration.<xref ref-type="bibr" rid="article-30100.r11">[11]</xref>&#x000a0;The white pulp is responsible for immune activity against pathogens (eg,&#x000a0;<italic toggle="yes">Neisseria meningitides</italic>, <italic toggle="yes">Streptococcus pneumonia</italic>, and <italic toggle="yes">Hemophilus influenza </italic>type b). The red pulp, composed of matrices of sinuses and cords, filters the blood, removing old or defective erythrocytes (ie, hemocatheresis). Up to 90% of splenectomized patients experience thrombocytosis postoperatively due to the loss of splenic sequestration.<xref ref-type="bibr" rid="article-30100.r12">[12]</xref><xref ref-type="bibr" rid="article-30100.r6">[6]</xref><xref ref-type="bibr" rid="article-30100.r13">[13]</xref>&#x000a0;A&#x000a0;hyposplenic or asplenic functional state can also lead to an elevated platelet count, as the thrombocytes bypass the modulating effect of the spleen. Other morphological effects can be seen in peripheral blood smears, including Howell-Jolly bodies (nuclear remnants), pitted erythrocytes with Pappenheimer bodies (iron deposits), and Heinz bodies (hemoglobin aggregates).<xref ref-type="bibr" rid="article-30100.r11">[11]</xref>&#x000a0;</p>
        <p>The risk of thrombosis is as high as 5% in the few weeks following splenectomy and can result in acute myocardial infarction, portal vein thrombosis, splenic vein thrombosis, mesenteric vein thrombosis, or pulmonary embolism.<xref ref-type="bibr" rid="article-30100.r14">[14]</xref><xref ref-type="bibr" rid="article-30100.r6">[6]</xref><xref ref-type="bibr" rid="article-30100.r15">[15]</xref>&#x000a0;Platelet counts greater than 800,000/&#x003bc;L can be observed in patients, with a normalizing gradual decrease occurring within weeks to years.<xref ref-type="bibr" rid="article-30100.r16">[16]</xref> Some experts recommend thromboprophylaxis in the immediate postoperative period as a preventative strategy, while others advocate the use of hydroxycarbamide chemotherapy due to its cytoreductive effect.<xref ref-type="bibr" rid="article-30100.r11">[11]</xref><xref ref-type="bibr" rid="article-30100.r17">[17]</xref><xref ref-type="bibr" rid="article-30100.r18">[18]</xref>&#x000a0;Additionally, all patients with a functional splenic defect should be fully vaccinated.</p>
        <p>
<bold>Iron Deficiency</bold>
</p>
        <p>Reactive thrombocytosis accompanying iron deficiency anemia can occur independently or in association with erythropoietin or as an additive event related to cytokines.<xref ref-type="bibr" rid="article-30100.r19">[19]</xref><xref ref-type="bibr" rid="article-30100.r20">[20]</xref>&#x000a0;Erythropoietin levels increase in this type of anemia, stimulating erythropoietin receptors on megakaryocyte progenitors and leading to increased production of platelets. When iron deficiency anemia coexists with a comorbid condition, inflammation and cytokine effects (eg, IL6 or thrombopoietin) may further elevate a high platelet count.<xref ref-type="bibr" rid="article-30100.r21">[21]</xref>&#x000a0;This can result in extreme thrombocytosis or a thrombotic event in approximately 6% of cases.<xref ref-type="bibr" rid="article-30100.r5">[5]</xref>&#x000a0;However, repletion of iron stores typically normalizes the platelet count, and clinicians should consider other etiologies if counts do not respond. Additionally, large von Willebrand multimers can be absorbed when platelet counts exceed a million, leading to an acquired von Willebrand disease.<xref ref-type="bibr" rid="article-30100.r5">[5]</xref></p>
        <p>
<bold>Drugs</bold>
</p>
        <p>Drug-induced thrombocytosis can result from various causative factors.<xref ref-type="bibr" rid="article-30100.r22">[22]</xref>&#x000a0;One proposed mechanism is that certain drugs can cause the release of cytokines, particularly IL6, leading to thrombocytosis.<xref ref-type="bibr" rid="article-30100.r23">[23]</xref>&#x000a0;The increased IL6 would then lead to thrombocytosis. Many&#x000a0;drugs can induce thrombocytosis, with varying propensities to do so. Examples include low molecular weight heparin, vincristine, epinephrine, all-trans retinoic acid (ATRA), beta-lactam antibiotics, gemcitabine, and clozapine.<xref ref-type="bibr" rid="article-30100.r24">[24]</xref><xref ref-type="bibr" rid="article-30100.r23">[23]</xref>&#x000a0;Antibiotics such as ciprofloxacin, tazobactam, piperacillin, augmentin, and ceftazidime can produce significantly high thrombocytosis, but the platelet count usually normalizes once the drug is discontinued.<xref ref-type="bibr" rid="article-30100.r25">[25]</xref><xref ref-type="bibr" rid="article-30100.r26">[26]</xref><xref ref-type="bibr" rid="article-30100.r27">[27]</xref>&#x000a0;</p>
        <p>
<bold>Inflammatory Conditions</bold>
</p>
        <p>Rheumatoid arthritis, inflammatory bowel disease, sarcoidosis, and autoimmune antibody-mediated illnesses can cause thrombocytosis through inflammatory effects, particularly involving IL6.<xref ref-type="bibr" rid="article-30100.r28">[28]</xref>&#x000a0;Several diseases, such as rheumatic disease, celiac disease, polyarteritis nodosa, and giant cell arteritis, can present with a fever of unknown origin and an increased platelet count.<xref ref-type="bibr" rid="article-30100.r29">[29]</xref><xref ref-type="bibr" rid="article-30100.r30">[30]</xref>&#x000a0;Furthermore, a survey noted that thrombocytosis in these conditions has been associated with cancer in approximately 11% of cases.<xref ref-type="bibr" rid="article-30100.r31">[31]</xref> Although sarcoidosis can affect many organ systems, especially the lungs, bone marrow involvement can result in thrombocytosis.<xref ref-type="bibr" rid="article-30100.r31">[31]</xref>&#x000a0;In these patients, a high mean platelet volume correlates with active inflammatory disease and typically resolves with the treatment of sarcoidosis.</p>
        <p>Platelets can also mediate allergic inflammation using immunoglobulin E (IgE) receptors and dependent processer on their surfaces.<xref ref-type="bibr" rid="article-30100.r32">[32]</xref><xref ref-type="bibr" rid="article-30100.r33">[33]</xref>&#x000a0;Platelets can migrate out of the vasculature and into the airways, contributing to allergic reactions.<xref ref-type="bibr" rid="article-30100.r34">[34]</xref><xref ref-type="bibr" rid="article-30100.r35">[35]</xref> Alongside allergic reactions, chronic inflammation also increases the platelet count.<xref ref-type="bibr" rid="article-30100.r36">[36]</xref> A high mean platelet volume reflects the presence of young platelets released from the body's reserve.</p>
        <p>
<bold>Hemolysis</bold>
</p>
        <p>Most diseases with antibody-mediated hemolysis manifest thrombocytopenia. Conversely, some conditions, including cold agglutinin disease (CAD), cause thrombocytosis. Although classically associated with <italic toggle="yes">Mycoplasma pneumoniae</italic>, CAD is also linked to Epstein-Barr virus, cytomegalovirus, COVID-19, and malignant or lymphoproliferative diseases.<xref ref-type="bibr" rid="article-30100.r37">[37]</xref><xref ref-type="bibr" rid="article-30100.r38">[38]</xref>&#x000a0;<italic toggle="yes">Mycoplasma</italic>-associated hemolysis is due to cold agglutinins, the antibodies against the I antigen found on erythrocytes and respiratory endothelial cells.<xref ref-type="bibr" rid="article-30100.r39">[39]</xref><xref ref-type="bibr" rid="article-30100.r37">[37]</xref>&#x000a0;The IgM cold agglutinins bind to complement factor C1 and initiate the classic complement pathway.<xref ref-type="bibr" rid="article-30100.r37">[37]</xref>&#x000a0;</p>
        <p>Hemolysis itself has the propensity to cause endothelial dysfunction, leading to platelet activation and, thereby, the coagulation cascade.<xref ref-type="bibr" rid="article-30100.r40">[40]</xref>&#x000a0;Recent case studies have shown that thrombocytosis can exist in the setting of CAD; however, there was concern that the patient may have had an increased platelet count due to a concurrent infection.<xref ref-type="bibr" rid="article-30100.r39">[39]</xref>&#x000a0;Due to the increased thrombotic risk, thromboprophylaxis is recommended for acute hemolysis and patients considering splenectomy.<xref ref-type="bibr" rid="article-30100.r40">[40]</xref>&#x000a0;Other sources recommend checking for antiphospholipid antibodies as well.<xref ref-type="bibr" rid="article-30100.r41">[41]</xref>&#x000a0;</p>
        <p>
<bold>Metastatic Cancer and Lymphoma</bold>
</p>
        <p>Platelets have an established association with malignancies.<xref ref-type="bibr" rid="article-30100.r42">[42]</xref>&#x000a0;Cases of acute promyelocytic leukemia treated with ATRA can release cytokines (eg, IL6), resulting in platelet counts exceeding a million. Thrombocytosis predicts a decrease in disease-free survival and overall survival in patients being treated for gastric cancer.<xref ref-type="bibr" rid="article-30100.r43">[43]</xref> The presence of thrombocytosis correlates with advanced disease stages and frequent lymphatic and renal involvement. Thrombocytosis has also been observed in patients with ovarian cancer undergoing chemotherapy.<xref ref-type="bibr" rid="article-30100.r44">[44]</xref>&#x000a0;Additionally, thrombocytosis commonly occurs with colon, lung, kidney, esophagus, stomach, pancreas, ovarian, breast, cervical, and endometrial cancers.<xref ref-type="bibr" rid="article-30100.r44">[44]</xref><xref ref-type="bibr" rid="article-30100.r45">[45]</xref>&#x000a0;</p>
        <p>Tumors can directly cause cytokine release, particularly IL6, which increases the liver's thrombopoietin (mRNA) production, leading to reactive thrombocytosis.<xref ref-type="bibr" rid="article-30100.r46">[46]</xref>&#x000a0;Tumors can also establish their blood supply via an angiogenic process regulated by platelets through alpha granules.<xref ref-type="bibr" rid="article-30100.r47">[47]</xref>&#x000a0;These tumors contain proangiogenic proteins, including vascular endothelial growth factor, for which platelets are the blood's largest repository.<xref ref-type="bibr" rid="article-30100.r48">[48]</xref>&#x000a0;Subsequently, by utilizing platelets, tumors increase and sustain their metastatic networks.</p>
        <p>
<bold>Exercise</bold>
</p>
        <p>A patient's exercise regimen can influence platelet release, activation, and function. Studies have confirmed that acute exercise leads to a transient increase in platelet count, partially due to hemoconcentration and mobilization from the liver, lungs, and spleen. However, regular exercise training reduces platelet adhesion and aggregation, thereby exerting an antithrombotic effect.<xref ref-type="bibr" rid="article-30100.r49">[49]</xref><xref ref-type="bibr" rid="article-30100.r50">[50]</xref><xref ref-type="bibr" rid="article-30100.r51">[51]</xref></p>
      </sec>
      <sec id="article-30100.s4" sec-type="Epidemiology">
        <title>Epidemiology</title>
        <p>Secondary thrombocytosis is more common than primary thrombocytosis. Approximately 75% of individuals without prior myeloproliferative disorders develop thrombocytosis after splenectomy.<xref ref-type="bibr" rid="article-30100.r6">[6]</xref>&#x000a0;In cases of iron deficiency anemia, the prevalence of reactive thrombocytosis is about 30%. Additionally, a Chinese study found that around 25.9% of children with respiratory tract infections had a platelet count of more than or equal to 500&#x02009;&#x000d7;&#x02009;10/L.<xref ref-type="bibr" rid="article-30100.r52">[52]</xref>&#x000a0;</p>
        <p>In an Italian study, 50% of children aged 1 to 24 months who were hospitalized for community-acquired infections developed thrombocytosis.<xref ref-type="bibr" rid="article-30100.r53">[53]</xref>&#x000a0;Typically, preterm infants have lower platelet counts at birth, while term and late-preterm infants often experience thrombocytosis that peaks shortly after birth and then declines within the first month.<xref ref-type="bibr" rid="article-30100.r54">[54]</xref>&#x000a0;High platelet counts in young children are commonly associated with respiratory infections and, less frequently, autoimmune diseases.<xref ref-type="bibr" rid="article-30100.r55">[55]</xref>&#x000a0;A specific race, sex, or age has not been found to have an increased prevalence of secondary thrombocytosis.</p>
      </sec>
      <sec id="article-30100.s5" sec-type="Pathophysiology">
        <title>Pathophysiology</title>
        <p>In the bone marrow, stem cells differentiate into large cells called megakaryocytes, which then produce platelets. Each megakaryocyte can generate between 5000 and 10,000 platelets. The pathophysiology of secondary thrombocytosis can vary depending on its underlying cause. Animal studies have demonstrated a connection between inflammation and thrombus formation through IL6 and platelets.<xref ref-type="bibr" rid="article-30100.r56">[56]</xref><xref ref-type="bibr" rid="article-30100.r57">[57]</xref>&#x000a0;</p>
        <p>Inflammation augments the release of IL6, which, in turn, stimulates proplatelet production by megakaryocytes and enhances hepatic thrombopoietin production. These mechanisms contribute to thrombocytosis, which can lead to thrombosis. Thrombocytosis may be driven by overproduction of thrombopoietin, IL6, other cytokines, or catecholamines in inflammatory, infectious, or neoplastic conditions or secondary to stress.<xref ref-type="bibr" rid="article-30100.r58">[58]</xref><xref ref-type="bibr" rid="article-30100.r59">[59]</xref>&#x000a0;In iron deficiency anemia, elevated platelet counts result from increased megakaryocyte proliferation, while in asplenia, decreased platelet sequestration is the primary cause of thrombocytosis.&#x000a0;</p>
      </sec>
      <sec id="article-30100.s6" sec-type="History and Physical">
        <title>History and Physical</title>
        <p>
<bold>Clinical Symptoms</bold>
</p>
        <p>Secondary thrombocytosis is primarily an incidental laboratory finding and typically does not directly cause symptoms. However, symptoms may arise due to the underlying cause of the reactive thrombocytosis. Clinicians should take a focused history to investigate potential causes or complications of thrombocytosis, including:</p>
        <list list-type="bullet">
          <list-item>
            <p>Prior trauma or surgery</p>
          </list-item>
          <list-item>
            <p>History of&#x000a0;splenectomy or hemolysis</p>
          </list-item>
          <list-item>
            <p>Symptoms suggestive of infection, inflammation, or malignancy (eg,&#x000a0;fever, sweats, weight loss, and fatigue)</p>
          </list-item>
          <list-item>
            <p>History of bleeding (eg, menorrhagia or gastrointestinal), iron deficiency, or chronic hematologic disorder</p>
          </list-item>
          <list-item>
            <p>History of arterial or venous thrombosis</p>
          </list-item>
          <list-item>
            <p>Medications</p>
          </list-item>
          <list-item>
            <p>Smoking and alcohol consumption</p>
          </list-item>
        </list>
        <p>
<bold>Physical Examination Findings</bold>
</p>
        <p>Findings from the physical examination consistent with reactive thrombocytosis may include:&#x000a0;</p>
        <list list-type="bullet">
          <list-item>
            <p>Cutaneous or mucosal bleeding or bruising</p>
          </list-item>
          <list-item>
            <p>Lymphadenopathy</p>
          </list-item>
          <list-item>
            <p>Hepatosplenomegaly</p>
          </list-item>
          <list-item>
            <p>Signs of arterial or venous thrombosis&#x000a0;</p>
          </list-item>
        </list>
      </sec>
      <sec id="article-30100.s7" sec-type="Evaluation">
        <title>Evaluation</title>
        <p>Thrombocytosis, or thrombocythemia, is diagnosed through a complete blood count showing a platelet count greater than 450,000/&#x003bc;L.<xref ref-type="bibr" rid="article-30100.r2">[2]</xref>&#x000a0;Additional laboratory tests may be performed to differentiate between primary and secondary thrombocytosis in patients with this finding.<xref ref-type="bibr" rid="article-30100.r3">[3]</xref>&#x000a0;Because primary thrombocytosis results from unregulated platelet production in the bone marrow, the following laboratory diagnostic studies can help identify the underlying cause:</p>
        <list list-type="bullet">
          <list-item>
            <p>Peripheral blood smear&#x000a0;</p>
          </list-item>
          <list-item>
            <p>Erythrocyte sedimentation rate as an inflammatory gauge</p>
          </list-item>
          <list-item>
            <p>C-reactive protein as an inflammatory gauge</p>
          </list-item>
          <list-item>
            <p>Antinuclear antibody and rheumatoid factor</p>
          </list-item>
          <list-item>
            <p>Iron studies (eg, serum iron, total iron-binding capacity, and serum ferritin)&#x000a0;<xref ref-type="bibr" rid="article-30100.r4">[4]</xref>&#x000a0;</p>
          </list-item>
        </list>
        <p>However, additional tests such as genetic testing and a bone marrow biopsy may be considered if laboratory studies do not clarify whether the thrombocytosis is primary or secondary.</p>
      </sec>
      <sec id="article-30100.s8" sec-type="Treatment / Management">
        <title>Treatment / Management</title>
        <p>Secondary&#x000a0;thrombocytosis resolves with treatment of the underlying etiology. Therefore, appropriate management should be initiated once the reactive condition, the causative factor, has been identified.<xref ref-type="bibr" rid="article-30100.r60">[60]</xref>&#x000a0;For example, the normalization of platelet counts can be achieved by iron supplementation in&#x000a0;inflammatory bowel&#x000a0;patients.<xref ref-type="bibr" rid="article-30100.r61">[61]</xref><xref ref-type="bibr" rid="article-30100.r62">[62]</xref>&#x000a0;</p>
        <p>Antiplatelet treatments, such as aspirin, are generally not indicated in secondary thrombocytosis due to the very low risk of thrombosis. However, antithrombotic therapy may be considered for patients with platelet counts exceeding 1,000,000/&#x003bc;L, those experiencing complications from thrombocytosis, or those at risk of developing such complications.<xref ref-type="bibr" rid="article-30100.r63">[63]</xref>&#x000a0;Plateletpheresis may be considered for patients with evidence of thrombosis or active bleeding; although its effects are temporary, it can rapidly reduce platelet counts.&#x000a0;</p>
      </sec>
      <sec id="article-30100.s9" sec-type="Differential Diagnosis">
        <title>Differential Diagnosis</title>
        <p>Differential diagnoses for secondary thrombocytosis include:</p>
        <list list-type="bullet">
          <list-item>
            <p>(Familial) Essential thrombocythemia: The presence&#x000a0;of JAK2, CALB, and MPL favors this diagnosis.<xref ref-type="bibr" rid="article-30100.r64">[64]</xref></p>
          </list-item>
          <list-item>
            <p>Myelodysplastic syndrome (rare)</p>
          </list-item>
          <list-item>
            <p>Polycythemia vera</p>
          </list-item>
          <list-item>
            <p>Chronic myeloid leukemia</p>
          </list-item>
          <list-item>
            <p>Myelofibrosis</p>
          </list-item>
          <list-item>
            <p>Spurious thrombocytosis: Results from nonplatelet entities being counted as platelets.<xref ref-type="bibr" rid="article-30100.r5">[5]</xref></p>
          </list-item>
          <list-item>
            <p>Pseudothrombocytosis: Akin to spurious thrombocytosis; falsely elevated platelet count due to disease entities or compounds.<xref ref-type="bibr" rid="article-30100.r65">[65]</xref><xref ref-type="bibr" rid="article-30100.r66">[66]</xref><xref ref-type="bibr" rid="article-30100.r67">[67]</xref><xref ref-type="bibr" rid="article-30100.r68">[68]</xref></p>
          </list-item>
        </list>
      </sec>
      <sec id="article-30100.s10" sec-type="Prognosis">
        <title>Prognosis</title>
        <p>Secondary&#x000a0;thrombocytosis is usually transient and resolves when the underlying condition is addressed. The overall prognosis depends on the primary causative condition. In some disorders, such as chronic obstructive pulmonary disease and certain gastrointestinal cancers (eg, esophageal and colorectal cancer), the presence of thrombocytosis may indicate a poorer prognosis.<xref ref-type="bibr" rid="article-30100.r69">[69]</xref>&#x000a0;</p>
      </sec>
      <sec id="article-30100.s11" sec-type="Complications">
        <title>Complications</title>
        <p>Complications specifically associated with secondary thrombocytosis are rare. However, clinicians should be familiar with the general complications of thrombocytosis, including:</p>
        <list list-type="bullet">
          <list-item>
            <p>Arterial and venous thrombosis, which leads to stroke, myocardial infarction, and mesenteric ischemia (platelet counts &#x0003e;1,000,000/&#x003bc;L increase the risk of thrombosis) <xref ref-type="bibr" rid="article-30100.r70">[70]</xref><xref ref-type="bibr" rid="article-30100.r71">[71]</xref></p>
          </list-item>
          <list-item>
            <p>Bleeding</p>
          </list-item>
          <list-item>
            <p>Spontaneous&#x000a0;abortion</p>
          </list-item>
          <list-item>
            <p>Intrauterine death or intrauterine growth retardation</p>
          </list-item>
          <list-item>
            <p>Transformation to acute myeloid leukemia and primary myelofibrosis</p>
          </list-item>
        </list>
      </sec>
      <sec id="article-30100.s12" sec-type="Deterrence and Patient Education">
        <title>Deterrence and Patient Education</title>
        <p>Patients should be advised that although secondary thrombocytosis is typically an incidental finding, addressing the underlying etiology is still essential, as thrombocytosis can&#x000a0;lead to&#x000a0;complications such as thrombosis. In addition, patients should also be informed that reactive thrombocytosis is a laboratory anomaly that resolves when the underlying causative condition is addressed. Therefore, compliance with treatment recommendations&#x000a0;and follow-up appointments is essential for effective management.</p>
      </sec>
      <sec id="article-30100.s13" sec-type="Enhancing Healthcare Team Outcomes ">
        <title>Enhancing Healthcare Team Outcomes </title>
        <p>Platelets act as acute-phase reactants, and secondary thrombocytosis can occur&#x000a0;due to acute underlying infections, tissue damage, chronic inflammatory disorders, and malignancies. An interprofessional healthcare team comprising primary care providers, internists, surgeons, emergency room staff, pathologists, and laboratory technicians should collaborate to identify and treat patients with this secondary thrombocytosis. A thorough history and physical examination are essential to exclude common causes of reactive thrombocytosis.<xref ref-type="bibr" rid="article-30100.r5">[5]</xref>&#x000a0;</p>
        <p>For patients with secondary thrombocytosis where the underlying cause remains unidentified, a comprehensive evaluation is necessary to rule out occult disorders such as malignancies. Thrombocytosis can arise in various clinical contexts with diverse underlying etiologies. In certain patients, differentiating primary from secondary causes of thrombocytosis can be challenging, yet this distinction is crucial for appropriate treatment and prognostic implications. In such cases, consulting a hematologist is recommended. Patient education and regular follow-up are also essential components of effective management.</p>
      </sec>
      <sec id="article-30100.s14">
        <title>Review Questions</title>
        <list list-type="bullet">
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=30100&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=30100">Access free multiple choice questions on this topic.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://mdsearchlight.com/blood-disorders/secondary-thrombocytosis/?utm_source=pubmedlink&#x00026;utm_campaign=MDS&#x00026;utm_content=30100">Click here for a simplified version.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/articlelibrary/commentarticle/30100/?utm_source=pubmed&#x00026;utm_campaign=comments&#x00026;utm_content=30100">Comment on this article.</ext-link>
</p>
          </list-item>
        </list>
      </sec>
    </body>
    <back>
      <ref-list id="article-30100.s15">
        <title>References</title>
        <ref id="article-30100.r1">
          <label>1</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Schafer</surname>
                <given-names>AI</given-names>
              </name>
            </person-group>
            <article-title>Thrombocytosis: too much of a good thing?</article-title>
            <source>Trans Am Clin Climatol Assoc</source>
            <year>2002</year>
            <volume>113</volume>
            <fpage>68</fpage>
            <page-range>68-76; discussion 76-7</page-range>
            <pub-id pub-id-type="pmid">12053719</pub-id>
          </element-citation>
        </ref>
        <ref id="article-30100.r2">
          <label>2</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Sa&#x00142;acki</surname>
                <given-names>AJ</given-names>
              </name>
              <name>
                <surname>Wysoki&#x00144;ski</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <article-title>Reactive thrombocytosis resulting from frequent blood donations as an extremely rare cause of ST Segment Elevation Myocardial Infarction in the case of a 19-year-old male.</article-title>
            <source>Ann Agric Environ Med</source>
            <year>2018</year>
            <month>Dec</month>
            <day>20</day>
            <volume>25</volume>
            <issue>4</issue>
            <fpage>602</fpage>
            <page-range>602-604</page-range>
            <pub-id pub-id-type="pmid">30586983</pub-id>
          </element-citation>
        </ref>
        <ref id="article-30100.r3">
          <label>3</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Schafer</surname>
                <given-names>AI</given-names>
              </name>
            </person-group>
            <article-title>Thrombocytosis.</article-title>
            <source>JAMA</source>
            <year>2015</year>
            <month>Sep</month>
            <day>15</day>
            <volume>314</volume>
            <issue>11</issue>
            <fpage>1171</fpage>
            <page-range>1171-2</page-range>
            <pub-id pub-id-type="pmid">26372588</pub-id>
          </element-citation>
        </ref>
        <ref id="article-30100.r4">
          <label>4</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Rumi</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Cazzola</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>Diagnosis, risk stratification, and response evaluation in classical myeloproliferative neoplasms.</article-title>
            <source>Blood</source>
            <year>2017</year>
            <month>Feb</month>
            <day>09</day>
            <volume>129</volume>
            <issue>6</issue>
            <fpage>680</fpage>
            <page-range>680-692</page-range>
            <pub-id pub-id-type="pmid">28028026</pub-id>
          </element-citation>
        </ref>
        <ref id="article-30100.r5">
          <label>5</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Bleeker</surname>
                <given-names>JS</given-names>
              </name>
              <name>
                <surname>Hogan</surname>
                <given-names>WJ</given-names>
              </name>
            </person-group>
            <article-title>Thrombocytosis: diagnostic evaluation, thrombotic risk stratification, and risk-based management strategies.</article-title>
            <source>Thrombosis</source>
            <year>2011</year>
            <volume>2011</volume>
            <fpage>536062</fpage>
            <pub-id pub-id-type="pmid">22084665</pub-id>
          </element-citation>
        </ref>
        <ref id="article-30100.r6">
          <label>6</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Khan</surname>
                <given-names>PN</given-names>
              </name>
              <name>
                <surname>Nair</surname>
                <given-names>RJ</given-names>
              </name>
              <name>
                <surname>Olivares</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Tingle</surname>
                <given-names>LE</given-names>
              </name>
              <name>
                <surname>Li</surname>
                <given-names>Z</given-names>
              </name>
            </person-group>
            <article-title>Postsplenectomy reactive thrombocytosis.</article-title>
            <source>Proc (Bayl Univ Med Cent)</source>
            <year>2009</year>
            <month>Jan</month>
            <volume>22</volume>
            <issue>1</issue>
            <fpage>9</fpage>
            <page-range>9-12</page-range>
            <pub-id pub-id-type="pmid">19169391</pub-id>
          </element-citation>
        </ref>
        <ref id="article-30100.r7">
          <label>7</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Buss</surname>
                <given-names>DH</given-names>
              </name>
              <name>
                <surname>Cashell</surname>
                <given-names>AW</given-names>
              </name>
              <name>
                <surname>O'Connor</surname>
                <given-names>ML</given-names>
              </name>
              <name>
                <surname>Richards</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Case</surname>
                <given-names>LD</given-names>
              </name>
            </person-group>
            <article-title>Occurrence, etiology, and clinical significance of extreme thrombocytosis: a study of 280 cases.</article-title>
            <source>Am J Med</source>
            <year>1994</year>
            <month>Mar</month>
            <volume>96</volume>
            <issue>3</issue>
            <fpage>247</fpage>
            <page-range>247-53</page-range>
            <pub-id pub-id-type="pmid">8154513</pub-id>
          </element-citation>
        </ref>
        <ref id="article-30100.r8">
          <label>8</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Bano</surname>
                <given-names>Z</given-names>
              </name>
              <name>
                <surname>Ahsan</surname>
                <given-names>T</given-names>
              </name>
            </person-group>
            <article-title>Reactive thrombocytosis with digital gangrene.</article-title>
            <source>J Pak Med Assoc</source>
            <year>2008</year>
            <month>Dec</month>
            <volume>58</volume>
            <issue>12</issue>
            <fpage>703</fpage>
            <page-range>703-4</page-range>
            <pub-id pub-id-type="pmid">19157329</pub-id>
          </element-citation>
        </ref>
        <ref id="article-30100.r9">
          <label>9</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Rose</surname>
                <given-names>SR</given-names>
              </name>
              <name>
                <surname>Petersen</surname>
                <given-names>NJ</given-names>
              </name>
              <name>
                <surname>Gardner</surname>
                <given-names>TJ</given-names>
              </name>
              <name>
                <surname>Hamill</surname>
                <given-names>RJ</given-names>
              </name>
              <name>
                <surname>Trautner</surname>
                <given-names>BW</given-names>
              </name>
            </person-group>
            <article-title>Etiology of thrombocytosis in a general medicine population: analysis of 801 cases with emphasis on infectious causes.</article-title>
            <source>J Clin Med Res</source>
            <year>2012</year>
            <month>Dec</month>
            <volume>4</volume>
            <issue>6</issue>
            <fpage>415</fpage>
            <page-range>415-23</page-range>
            <pub-id pub-id-type="pmid">23226175</pub-id>
          </element-citation>
        </ref>
        <ref id="article-30100.r10">
          <label>10</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Kenya</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Bunawan</surname>
                <given-names>NC</given-names>
              </name>
              <name>
                <surname>Nugroho</surname>
                <given-names>HM</given-names>
              </name>
              <name>
                <surname>Harlivasari</surname>
                <given-names>AD</given-names>
              </name>
              <name>
                <surname>Sigarlaki</surname>
                <given-names>ED</given-names>
              </name>
              <name>
                <surname>Rinaldi</surname>
                <given-names>I</given-names>
              </name>
            </person-group>
            <article-title>COVID-19 with Extreme Thrombocytosis: A Case Report and Its Possible Mechanisms.</article-title>
            <source>Caspian J Intern Med</source>
            <year>2022</year>
            <volume>13</volume>
            <issue>Suppl 3</issue>
            <fpage>289</fpage>
            <page-range>289-294</page-range>
            <pub-id pub-id-type="pmid">35872678</pub-id>
          </element-citation>
        </ref>
        <ref id="article-30100.r11">
          <label>11</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Lenti</surname>
                <given-names>MV</given-names>
              </name>
              <name>
                <surname>Luu</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Carsetti</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Osier</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Ogwang</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Nnodu</surname>
                <given-names>OE</given-names>
              </name>
              <name>
                <surname>Wiedermann</surname>
                <given-names>U</given-names>
              </name>
              <name>
                <surname>Spencer</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Locatelli</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Corazza</surname>
                <given-names>GR</given-names>
              </name>
              <name>
                <surname>Di Sabatino</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <article-title>Asplenia and spleen hypofunction.</article-title>
            <source>Nat Rev Dis Primers</source>
            <year>2022</year>
            <month>Nov</month>
            <day>03</day>
            <volume>8</volume>
            <issue>1</issue>
            <fpage>71</fpage>
            <pub-id pub-id-type="pmid">36329079</pub-id>
          </element-citation>
        </ref>
        <ref id="article-30100.r12">
          <label>12</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Chia</surname>
                <given-names>TL</given-names>
              </name>
              <name>
                <surname>Chesney</surname>
                <given-names>TR</given-names>
              </name>
              <name>
                <surname>Isa</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Mnatzakanian</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Colak</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Belmont</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Hirpara</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Veigas</surname>
                <given-names>PV</given-names>
              </name>
              <name>
                <surname>Acuna</surname>
                <given-names>SA</given-names>
              </name>
              <name>
                <surname>Rizoli</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Rezende-Neto</surname>
                <given-names>J</given-names>
              </name>
            </person-group>
            <article-title>Thrombocytosis in splenic trauma: In-hospital course and association with venous thromboembolism.</article-title>
            <source>Injury</source>
            <year>2017</year>
            <month>Jan</month>
            <volume>48</volume>
            <issue>1</issue>
            <fpage>142</fpage>
            <page-range>142-147</page-range>
            <pub-id pub-id-type="pmid">27451291</pub-id>
          </element-citation>
        </ref>
        <ref id="article-30100.r13">
          <label>13</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Luu</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Woolley</surname>
                <given-names>IJ</given-names>
              </name>
              <name>
                <surname>Andrews</surname>
                <given-names>RK</given-names>
              </name>
            </person-group>
            <article-title>Platelet phenotype and function in the absence of splenic sequestration (Review).</article-title>
            <source>Platelets</source>
            <year>2021</year>
            <month>Jan</month>
            <day>02</day>
            <volume>32</volume>
            <issue>1</issue>
            <fpage>47</fpage>
            <page-range>47-52</page-range>
            <pub-id pub-id-type="pmid">32106750</pub-id>
          </element-citation>
        </ref>
        <ref id="article-30100.r14">
          <label>14</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Al-Jafar</surname>
                <given-names>HA</given-names>
              </name>
              <name>
                <surname>Taqi</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Madda</surname>
                <given-names>JP</given-names>
              </name>
              <name>
                <surname>Abdullah</surname>
                <given-names>TA</given-names>
              </name>
            </person-group>
            <article-title>Splenectomy complicated by sustained extreme thrombocytosis and extensive portosplenomesenteric vein thrombosis in pyrimidine 5'-nucleotidase deficiency.</article-title>
            <source>BMJ Case Rep</source>
            <year>2013</year>
            <month>Nov</month>
            <day>28</day>
            <volume>2013</volume>
            <pub-id pub-id-type="pmid">24287477</pub-id>
          </element-citation>
        </ref>
        <ref id="article-30100.r15">
          <label>15</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Zvizdic</surname>
                <given-names>Z</given-names>
              </name>
              <name>
                <surname>Kovacevic</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Milisic</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Jonuzi</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Vranic</surname>
                <given-names>S</given-names>
              </name>
            </person-group>
            <article-title>Clinical course and short-term outcome of postsplenectomy reactive thrombocytosis in children without myeloproliferative disorders: A single institutional experience from a developing country.</article-title>
            <source>PLoS One</source>
            <year>2020</year>
            <volume>15</volume>
            <issue>8</issue>
            <fpage>e0237016</fpage>
            <pub-id pub-id-type="pmid">32756575</pub-id>
          </element-citation>
        </ref>
        <ref id="article-30100.r16">
          <label>16</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>J</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Acharya</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Huse</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Sachdev</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <article-title>Reactive Thrombocytosis: A Bizarre Consequence of Splenectomy.</article-title>
            <source>Cureus</source>
            <year>2024</year>
            <month>Apr</month>
            <volume>16</volume>
            <issue>4</issue>
            <fpage>e57455</fpage>
            <pub-id pub-id-type="pmid">38699114</pub-id>
          </element-citation>
        </ref>
        <ref id="article-30100.r17">
          <label>17</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Ejikeme</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Elkattawy</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Kayode-Ajala</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Ayad</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Al-Nasseri</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Kessler</surname>
                <given-names>W</given-names>
              </name>
            </person-group>
            <article-title>Reactive Thrombocytosis after Splenectomy in Hereditary Spherocytosis: Case Report and Literature Review.</article-title>
            <source>Eur J Case Rep Intern Med</source>
            <year>2021</year>
            <volume>8</volume>
            <issue>7</issue>
            <fpage>002673</fpage>
            <pub-id pub-id-type="pmid">34377694</pub-id>
          </element-citation>
        </ref>
        <ref id="article-30100.r18">
          <label>18</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Sarbay</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Akbayram</surname>
                <given-names>S</given-names>
              </name>
            </person-group>
            <article-title>Secondary severe thrombocytosis in a patient who underwent splenectomy due to hereditary spherocytosis and its treatment using hydroxyurea.</article-title>
            <source>Pan Afr Med J</source>
            <year>2019</year>
            <volume>32</volume>
            <fpage>175</fpage>
            <pub-id pub-id-type="pmid">31303944</pub-id>
          </element-citation>
        </ref>
        <ref id="article-30100.r19">
          <label>19</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Akan</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>G&#x000fc;ven</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Aydogdu</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Arat</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Beksa&#x000e7;</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Dalva</surname>
                <given-names>K</given-names>
              </name>
            </person-group>
            <article-title>Thrombopoietic cytokines in patients with iron deficiency anemia with or without thrombocytosis.</article-title>
            <source>Acta Haematol</source>
            <year>2000</year>
            <volume>103</volume>
            <issue>3</issue>
            <fpage>152</fpage>
            <page-range>152-6</page-range>
            <pub-id pub-id-type="pmid">10940653</pub-id>
          </element-citation>
        </ref>
        <ref id="article-30100.r20">
          <label>20</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Evstatiev</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Bukaty</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Jimenez</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Kulnigg-Dabsch</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Surman</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Schmid</surname>
                <given-names>W</given-names>
              </name>
              <name>
                <surname>Eferl</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Lippert</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Scheiber-Mojdehkar</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Kvasnicka</surname>
                <given-names>HM</given-names>
              </name>
              <name>
                <surname>Khare</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Gasche</surname>
                <given-names>C</given-names>
              </name>
            </person-group>
            <article-title>Iron deficiency alters megakaryopoiesis and platelet phenotype independent of thrombopoietin.</article-title>
            <source>Am J Hematol</source>
            <year>2014</year>
            <month>May</month>
            <volume>89</volume>
            <issue>5</issue>
            <fpage>524</fpage>
            <page-range>524-9</page-range>
            <pub-id pub-id-type="pmid">24464533</pub-id>
          </element-citation>
        </ref>
        <ref id="article-30100.r21">
          <label>21</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Dignass</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Farrag</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Stein</surname>
                <given-names>J</given-names>
              </name>
            </person-group>
            <article-title>Limitations of Serum Ferritin in Diagnosing Iron Deficiency in Inflammatory Conditions.</article-title>
            <source>Int J Chronic Dis</source>
            <year>2018</year>
            <volume>2018</volume>
            <fpage>9394060</fpage>
            <pub-id pub-id-type="pmid">29744352</pub-id>
          </element-citation>
        </ref>
        <ref id="article-30100.r22">
          <label>22</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Zhou</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Bao</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Ma</surname>
                <given-names>J</given-names>
              </name>
            </person-group>
            <article-title>Hemolytic Anemia and Reactive Thrombocytosis Associated With Cefoperazone/Sulbactam.</article-title>
            <source>Front Pharmacol</source>
            <year>2019</year>
            <volume>10</volume>
            <fpage>1342</fpage>
            <pub-id pub-id-type="pmid">31798450</pub-id>
          </element-citation>
        </ref>
        <ref id="article-30100.r23">
          <label>23</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Docobo</surname>
                <given-names>RA</given-names>
              </name>
              <name>
                <surname>Bukhari</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Qutrio Baloch</surname>
                <given-names>Z</given-names>
              </name>
            </person-group>
            <article-title>Ertapenem-Induced Thrombocytosis.</article-title>
            <source>Cureus</source>
            <year>2017</year>
            <month>May</month>
            <day>19</day>
            <volume>9</volume>
            <issue>5</issue>
            <fpage>e1263</fpage>
            <pub-id pub-id-type="pmid">28652947</pub-id>
          </element-citation>
        </ref>
        <ref id="article-30100.r24">
          <label>24</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Vo</surname>
                <given-names>QT</given-names>
              </name>
              <name>
                <surname>Thompson</surname>
                <given-names>DF</given-names>
              </name>
            </person-group>
            <article-title>A Review and Assessment of Drug-Induced Thrombocytosis.</article-title>
            <source>Ann Pharmacother</source>
            <year>2019</year>
            <month>May</month>
            <volume>53</volume>
            <issue>5</issue>
            <fpage>523</fpage>
            <page-range>523-536</page-range>
            <pub-id pub-id-type="pmid">30525921</pub-id>
          </element-citation>
        </ref>
        <ref id="article-30100.r25">
          <label>25</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Finsterer</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Kotzailias</surname>
                <given-names>N</given-names>
              </name>
            </person-group>
            <article-title>Thrombocytosis under ciprofloxacin and tazobactam/piperacillin.</article-title>
            <source>Platelets</source>
            <year>2003</year>
            <month>Aug</month>
            <volume>14</volume>
            <issue>5</issue>
            <fpage>329</fpage>
            <page-range>329-31</page-range>
            <pub-id pub-id-type="pmid">12944250</pub-id>
          </element-citation>
        </ref>
        <ref id="article-30100.r26">
          <label>26</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Chen</surname>
                <given-names>HC</given-names>
              </name>
              <name>
                <surname>Wang</surname>
                <given-names>CY</given-names>
              </name>
              <name>
                <surname>Wang</surname>
                <given-names>CS</given-names>
              </name>
            </person-group>
            <article-title>Marked thrombocytosis during treatment with ceftazidime for pulmonary infection.</article-title>
            <source>Pharm World Sci</source>
            <year>2008</year>
            <month>Jan</month>
            <volume>30</volume>
            <issue>1</issue>
            <fpage>70</fpage>
            <page-range>70-2</page-range>
            <pub-id pub-id-type="pmid">17619167</pub-id>
          </element-citation>
        </ref>
        <ref id="article-30100.r27">
          <label>27</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Yang</surname>
                <given-names>CJ</given-names>
              </name>
              <name>
                <surname>Hwang</surname>
                <given-names>JJ</given-names>
              </name>
              <name>
                <surname>Hung</surname>
                <given-names>JY</given-names>
              </name>
              <name>
                <surname>Chong</surname>
                <given-names>IW</given-names>
              </name>
              <name>
                <surname>Huang</surname>
                <given-names>MS</given-names>
              </name>
            </person-group>
            <article-title>Extreme thrombocytosis under the treatment by amoxicillin/clavulanate.</article-title>
            <source>Pharm World Sci</source>
            <year>2006</year>
            <month>Oct</month>
            <volume>28</volume>
            <issue>5</issue>
            <fpage>326</fpage>
            <page-range>326-8</page-range>
            <pub-id pub-id-type="pmid">17111242</pub-id>
          </element-citation>
        </ref>
        <ref id="article-30100.r28">
          <label>28</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Korkmaz</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Demircioglu</surname>
                <given-names>S</given-names>
              </name>
            </person-group>
            <article-title>The Association of Neutrophil/Lymphocyte and Platelet/Lymphocyte Ratios and Hematological Parameters with Diagnosis, Stages, Extrapulmonary Involvement, Pulmonary Hypertension, Response to Treatment, and Prognosis in Patients with Sarcoidosis.</article-title>
            <source>Can Respir J</source>
            <year>2020</year>
            <volume>2020</volume>
            <fpage>1696450</fpage>
            <pub-id pub-id-type="pmid">33062080</pub-id>
          </element-citation>
        </ref>
        <ref id="article-30100.r29">
          <label>29</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Cunha</surname>
                <given-names>BA</given-names>
              </name>
              <name>
                <surname>Lortholary</surname>
                <given-names>O</given-names>
              </name>
              <name>
                <surname>Cunha</surname>
                <given-names>CB</given-names>
              </name>
            </person-group>
            <article-title>Fever of unknown origin: a clinical approach.</article-title>
            <source>Am J Med</source>
            <year>2015</year>
            <month>Oct</month>
            <volume>128</volume>
            <issue>10</issue>
            <fpage>1138.e1</fpage>
            <page-range>1138.e1-1138.e15</page-range>
            <pub-id pub-id-type="pmid">26093175</pub-id>
          </element-citation>
        </ref>
        <ref id="article-30100.r30">
          <label>30</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Clarke</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Hamilton</surname>
                <given-names>W</given-names>
              </name>
              <name>
                <surname>Price</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Bailey</surname>
                <given-names>SE</given-names>
              </name>
            </person-group>
            <article-title>Association of non-malignant diseases with thrombocytosis: a prospective cohort study in general practice.</article-title>
            <source>Br J Gen Pract</source>
            <year>2020</year>
            <month>Dec</month>
            <volume>70</volume>
            <issue>701</issue>
            <fpage>e852</fpage>
            <page-range>e852-e857</page-range>
            <pub-id pub-id-type="pmid">33199294</pub-id>
          </element-citation>
        </ref>
        <ref id="article-30100.r31">
          <label>31</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Long</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Bindernagel</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Austin</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Tarbox</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>Severe scalp sarcoidosis in an unlikely patient.</article-title>
            <source>JAAD Case Rep</source>
            <year>2020</year>
            <month>Nov</month>
            <volume>6</volume>
            <issue>11</issue>
            <fpage>1165</fpage>
            <page-range>1165-1166</page-range>
            <pub-id pub-id-type="pmid">33134463</pub-id>
          </element-citation>
        </ref>
        <ref id="article-30100.r32">
          <label>32</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Amison</surname>
                <given-names>RT</given-names>
              </name>
              <name>
                <surname>Cleary</surname>
                <given-names>SJ</given-names>
              </name>
              <name>
                <surname>Riffo-Vasquez</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Bajwa</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Page</surname>
                <given-names>CP</given-names>
              </name>
              <name>
                <surname>Pitchford</surname>
                <given-names>SC</given-names>
              </name>
            </person-group>
            <article-title>Platelets Play a Central Role in Sensitization to Allergen.</article-title>
            <source>Am J Respir Cell Mol Biol</source>
            <year>2018</year>
            <month>Jul</month>
            <volume>59</volume>
            <issue>1</issue>
            <fpage>96</fpage>
            <page-range>96-103</page-range>
            <pub-id pub-id-type="pmid">29365287</pub-id>
          </element-citation>
        </ref>
        <ref id="article-30100.r33">
          <label>33</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Idzko</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Pitchford</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Page</surname>
                <given-names>C</given-names>
              </name>
            </person-group>
            <article-title>Role of platelets in allergic airway inflammation.</article-title>
            <source>J Allergy Clin Immunol</source>
            <year>2015</year>
            <month>Jun</month>
            <volume>135</volume>
            <issue>6</issue>
            <fpage>1416</fpage>
            <page-range>1416-23</page-range>
            <pub-id pub-id-type="pmid">26051948</pub-id>
          </element-citation>
        </ref>
        <ref id="article-30100.r34">
          <label>34</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Page</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Pitchford</surname>
                <given-names>S</given-names>
              </name>
            </person-group>
            <article-title>Platelets and allergic inflammation.</article-title>
            <source>Clin Exp Allergy</source>
            <year>2014</year>
            <month>Jul</month>
            <volume>44</volume>
            <issue>7</issue>
            <fpage>901</fpage>
            <page-range>901-13</page-range>
            <pub-id pub-id-type="pmid">24708345</pub-id>
          </element-citation>
        </ref>
        <ref id="article-30100.r35">
          <label>35</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Yue</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Hu</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Fu</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Ruan</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Wu</surname>
                <given-names>C</given-names>
              </name>
            </person-group>
            <article-title>Emerging Roles of Platelets in Allergic Asthma.</article-title>
            <source>Front Immunol</source>
            <year>2022</year>
            <volume>13</volume>
            <fpage>846055</fpage>
            <pub-id pub-id-type="pmid">35432313</pub-id>
          </element-citation>
        </ref>
        <ref id="article-30100.r36">
          <label>36</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Randi</surname>
                <given-names>ML</given-names>
              </name>
              <name>
                <surname>Rossi</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Fabris</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Zerbinati</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Girolami</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <article-title>Atopic dermatitis and allergic diseases with thrombocytosis: a possible link.</article-title>
            <source>Ann Allergy Asthma Immunol</source>
            <year>1995</year>
            <month>Dec</month>
            <volume>75</volume>
            <issue>6 Pt 1</issue>
            <fpage>530</fpage>
            <page-range>530-2</page-range>
            <pub-id pub-id-type="pmid">8603285</pub-id>
          </element-citation>
        </ref>
        <ref id="article-30100.r37">
          <label>37</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Kumaravel Kanagavelu</surname>
                <given-names>AS</given-names>
              </name>
              <name>
                <surname>Nagumantry</surname>
                <given-names>SK</given-names>
              </name>
              <name>
                <surname>Sagi</surname>
                <given-names>SV</given-names>
              </name>
              <name>
                <surname>Oyibo</surname>
                <given-names>SO</given-names>
              </name>
            </person-group>
            <article-title>A Rare Case of Severe Hemolytic Anemia and Pulmonary Embolism Secondary to <italic>Mycoplasma pneumoniae</italic> Infection.</article-title>
            <source>J Med Cases</source>
            <year>2022</year>
            <month>Mar</month>
            <volume>13</volume>
            <issue>3</issue>
            <fpage>119</fpage>
            <page-range>119-124</page-range>
            <pub-id pub-id-type="pmid">35356396</pub-id>
          </element-citation>
        </ref>
        <ref id="article-30100.r38">
          <label>38</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Patil</surname>
                <given-names>NR</given-names>
              </name>
              <name>
                <surname>Herc</surname>
                <given-names>ES</given-names>
              </name>
              <name>
                <surname>Girgis</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>Cold Agglutinin Disease and Autoimmune Hemolytic Anemia with Pulmonary Embolism as a Presentation of COVID-19 Infection.</article-title>
            <source>Hematol Oncol Stem Cell Ther</source>
            <year>2022</year>
            <month>Dec</month>
            <day>23</day>
            <volume>15</volume>
            <issue>4</issue>
            <fpage>213</fpage>
            <page-range>213-216</page-range>
            <pub-id pub-id-type="pmid">32645300</pub-id>
          </element-citation>
        </ref>
        <ref id="article-30100.r39">
          <label>39</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Wid&#x000e9;n</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>J&#x000f6;nsson</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Karlsson</surname>
                <given-names>U</given-names>
              </name>
            </person-group>
            <article-title>Mycoplasma pneumonia with severe cold agglutinin hemolysis, thrombocytosis, leukemoid reaction and acute renal failure.</article-title>
            <source>IDCases</source>
            <year>2023</year>
            <volume>31</volume>
            <fpage>e01689</fpage>
            <pub-id pub-id-type="pmid">36687368</pub-id>
          </element-citation>
        </ref>
        <ref id="article-30100.r40">
          <label>40</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Capecchi</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Ciavarella</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Artoni</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Abbattista</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Martinelli</surname>
                <given-names>I</given-names>
              </name>
            </person-group>
            <article-title>Thrombotic Complications in Patients with Immune-Mediated Hemolysis.</article-title>
            <source>J Clin Med</source>
            <year>2021</year>
            <month>Apr</month>
            <day>18</day>
            <volume>10</volume>
            <issue>8</issue>
            <pub-id pub-id-type="pmid">33919638</pub-id>
          </element-citation>
        </ref>
        <ref id="article-30100.r41">
          <label>41</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Raut</surname>
                <given-names>MS</given-names>
              </name>
              <name>
                <surname>Rohra</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Shivnani</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Maheshwari</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Dubey</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Bhathiwal</surname>
                <given-names>RS</given-names>
              </name>
              <name>
                <surname>Sharma</surname>
                <given-names>D</given-names>
              </name>
            </person-group>
            <article-title>Bentall Surgery in a Patient with Cold Agglutinin and Antiphospholipid Antibody: Double Trouble.</article-title>
            <source>J Extra Corpor Technol</source>
            <year>2016</year>
            <month>Jun</month>
            <volume>48</volume>
            <issue>2</issue>
            <fpage>83</fpage>
            <page-range>83-5</page-range>
            <pub-id pub-id-type="pmid">27578899</pub-id>
          </element-citation>
        </ref>
        <ref id="article-30100.r42">
          <label>42</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Aldapt</surname>
                <given-names>MB</given-names>
              </name>
              <name>
                <surname>Kassem</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Al-Okka</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Ghasoub</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Soliman</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Abdulla</surname>
                <given-names>MA</given-names>
              </name>
              <name>
                <surname>Mudawi</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Ibrahim</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Yassin</surname>
                <given-names>MA</given-names>
              </name>
            </person-group>
            <article-title>Thrombocytosis in a male patient with acute promyelocytic leukaemia during all-trans retinoic (ATRA) acid treatment.</article-title>
            <source>Acta Biomed</source>
            <year>2018</year>
            <month>Apr</month>
            <day>03</day>
            <volume>89</volume>
            <issue>3-S</issue>
            <fpage>33</fpage>
            <page-range>33-37</page-range>
            <pub-id pub-id-type="pmid">29633731</pub-id>
          </element-citation>
        </ref>
        <ref id="article-30100.r43">
          <label>43</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Castro</surname>
                <given-names>BN</given-names>
              </name>
              <name>
                <surname>Costa</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Martins</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Amado</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Santos</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Gra&#x000e7;a</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Tavares</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Ferreira</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Viveiros</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Vale</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Oliveira</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>Prognostic impact of thrombocytosis in gastric cancer-A retrospective study.</article-title>
            <source>Porto Biomed J</source>
            <year>2024</year>
            <season>Mar-Apr</season>
            <volume>9</volume>
            <issue>2</issue>
            <fpage>247</fpage>
            <pub-id pub-id-type="pmid">38464547</pub-id>
          </element-citation>
        </ref>
        <ref id="article-30100.r44">
          <label>44</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Kim</surname>
                <given-names>MS</given-names>
              </name>
              <name>
                <surname>Baek</surname>
                <given-names>SH</given-names>
              </name>
              <name>
                <surname>Noh</surname>
                <given-names>JJ</given-names>
              </name>
              <name>
                <surname>Shim</surname>
                <given-names>JI</given-names>
              </name>
              <name>
                <surname>Kang</surname>
                <given-names>JH</given-names>
              </name>
              <name>
                <surname>Jeong</surname>
                <given-names>SY</given-names>
              </name>
              <name>
                <surname>Choi</surname>
                <given-names>CH</given-names>
              </name>
              <name>
                <surname>Kim</surname>
                <given-names>TJ</given-names>
              </name>
              <name>
                <surname>Lee</surname>
                <given-names>JW</given-names>
              </name>
              <name>
                <surname>Lee</surname>
                <given-names>YY</given-names>
              </name>
            </person-group>
            <article-title>Role of reactive thrombocytosis after primary cytoreductive surgery in advanced ovarian cancer.</article-title>
            <source>Front Oncol</source>
            <year>2022</year>
            <volume>12</volume>
            <fpage>926878</fpage>
            <pub-id pub-id-type="pmid">36158646</pub-id>
          </element-citation>
        </ref>
        <ref id="article-30100.r45">
          <label>45</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>J&#x000f3;sa</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Krzystanek</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Vass</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Lang</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Juh&#x000e1;sz</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Szil&#x000e1;gyi</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Tihanyi</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Hars&#x000e1;nyi</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Sz&#x000e1;ll&#x000e1;si</surname>
                <given-names>Z</given-names>
              </name>
              <name>
                <surname>Salamon</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Baranyai</surname>
                <given-names>Z</given-names>
              </name>
            </person-group>
            <article-title>Thrombocytosis of Liver Metastasis from Colorectal Cancer as Predictive Factor.</article-title>
            <source>Pathol Oncol Res</source>
            <year>2015</year>
            <month>Sep</month>
            <volume>21</volume>
            <issue>4</issue>
            <fpage>991</fpage>
            <page-range>991-7</page-range>
            <pub-id pub-id-type="pmid">25761795</pub-id>
          </element-citation>
        </ref>
        <ref id="article-30100.r46">
          <label>46</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Gold</surname>
                <given-names>LC</given-names>
              </name>
              <name>
                <surname>Macpherson</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Nobes</surname>
                <given-names>JH</given-names>
              </name>
              <name>
                <surname>Dow</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Furrie</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Jamieson</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Dillon</surname>
                <given-names>JF</given-names>
              </name>
            </person-group>
            <article-title>Thrombocytosis and abnormal liver enzymes: A trigger for investigation of underlying malignancy.</article-title>
            <source>PLoS One</source>
            <year>2022</year>
            <volume>17</volume>
            <issue>4</issue>
            <fpage>e0267124</fpage>
            <pub-id pub-id-type="pmid">35482741</pub-id>
          </element-citation>
        </ref>
        <ref id="article-30100.r47">
          <label>47</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Lin</surname>
                <given-names>RJ</given-names>
              </name>
              <name>
                <surname>Afshar-Kharghan</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Schafer</surname>
                <given-names>AI</given-names>
              </name>
            </person-group>
            <article-title>Paraneoplastic thrombocytosis: the secrets of tumor self-promotion.</article-title>
            <source>Blood</source>
            <year>2014</year>
            <month>Jul</month>
            <day>10</day>
            <volume>124</volume>
            <issue>2</issue>
            <fpage>184</fpage>
            <page-range>184-7</page-range>
            <pub-id pub-id-type="pmid">24868077</pub-id>
          </element-citation>
        </ref>
        <ref id="article-30100.r48">
          <label>48</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Giannakeas</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Narod</surname>
                <given-names>SA</given-names>
              </name>
            </person-group>
            <article-title>Incidence of Cancer Among Adults With Thrombocytosis in Ontario, Canada.</article-title>
            <source>JAMA Netw Open</source>
            <year>2021</year>
            <month>Aug</month>
            <day>02</day>
            <volume>4</volume>
            <issue>8</issue>
            <fpage>e2120633</fpage>
            <pub-id pub-id-type="pmid">34383058</pub-id>
          </element-citation>
        </ref>
        <ref id="article-30100.r49">
          <label>49</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Heber</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Volf</surname>
                <given-names>I</given-names>
              </name>
            </person-group>
            <article-title>Effects of Physical (In)activity on Platelet Function.</article-title>
            <source>Biomed Res Int</source>
            <year>2015</year>
            <volume>2015</volume>
            <fpage>165078</fpage>
            <pub-id pub-id-type="pmid">26557653</pub-id>
          </element-citation>
        </ref>
        <ref id="article-30100.r50">
          <label>50</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Beck</surname>
                <given-names>WR</given-names>
              </name>
              <name>
                <surname>Scariot</surname>
                <given-names>PP</given-names>
              </name>
              <name>
                <surname>Gobatto</surname>
                <given-names>CA</given-names>
              </name>
            </person-group>
            <article-title>Primary and secondary thrombocytosis induced by exercise and environmental luminosity.</article-title>
            <source>Bratisl Lek Listy</source>
            <year>2014</year>
            <volume>115</volume>
            <issue>10</issue>
            <fpage>607</fpage>
            <page-range>607-10</page-range>
            <pub-id pub-id-type="pmid">25573725</pub-id>
          </element-citation>
        </ref>
        <ref id="article-30100.r51">
          <label>51</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>McMullin</surname>
                <given-names>MF</given-names>
              </name>
            </person-group>
            <article-title>Diagnostic workflow for hereditary erythrocytosis and thrombocytosis.</article-title>
            <source>Hematology Am Soc Hematol Educ Program</source>
            <year>2019</year>
            <month>Dec</month>
            <day>06</day>
            <volume>2019</volume>
            <issue>1</issue>
            <fpage>391</fpage>
            <page-range>391-396</page-range>
            <pub-id pub-id-type="pmid">31808840</pub-id>
          </element-citation>
        </ref>
        <ref id="article-30100.r52">
          <label>52</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Zheng</surname>
                <given-names>SY</given-names>
              </name>
              <name>
                <surname>Xiao</surname>
                <given-names>QY</given-names>
              </name>
              <name>
                <surname>Xie</surname>
                <given-names>XH</given-names>
              </name>
              <name>
                <surname>Deng</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Ren</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Tian</surname>
                <given-names>DY</given-names>
              </name>
              <name>
                <surname>Luo</surname>
                <given-names>ZX</given-names>
              </name>
              <name>
                <surname>Luo</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Fu</surname>
                <given-names>Z</given-names>
              </name>
              <name>
                <surname>Huang</surname>
                <given-names>AL</given-names>
              </name>
              <name>
                <surname>Liu</surname>
                <given-names>EM</given-names>
              </name>
            </person-group>
            <article-title>Association between secondary thrombocytosis and viral respiratory tract infections in children.</article-title>
            <source>Sci Rep</source>
            <year>2016</year>
            <month>Mar</month>
            <day>11</day>
            <volume>6</volume>
            <fpage>22964</fpage>
            <pub-id pub-id-type="pmid">26965460</pub-id>
          </element-citation>
        </ref>
        <ref id="article-30100.r53">
          <label>53</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Indolfi</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Catania</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Bartolini</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Azzari</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Massai</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Poggi</surname>
                <given-names>GM</given-names>
              </name>
              <name>
                <surname>De Martino</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Resti</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>Incidence and clinical significance of reactive thrombocytosis in children aged 1 to 24 months, hospitalized for community-acquired infections.</article-title>
            <source>Platelets</source>
            <year>2008</year>
            <month>Sep</month>
            <volume>19</volume>
            <issue>6</issue>
            <fpage>409</fpage>
            <page-range>409-14</page-range>
            <pub-id pub-id-type="pmid">18925508</pub-id>
          </element-citation>
        </ref>
        <ref id="article-30100.r54">
          <label>54</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Jeon</surname>
                <given-names>GW</given-names>
              </name>
            </person-group>
            <article-title>Pathophysiology, classification, and complications of common asymptomatic thrombocytosis in newborn infants.</article-title>
            <source>Clin Exp Pediatr</source>
            <year>2022</year>
            <month>Apr</month>
            <volume>65</volume>
            <issue>4</issue>
            <fpage>182</fpage>
            <page-range>182-187</page-range>
            <pub-id pub-id-type="pmid">34665959</pub-id>
          </element-citation>
        </ref>
        <ref id="article-30100.r55">
          <label>55</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Shin</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Lee</surname>
                <given-names>DH</given-names>
              </name>
              <name>
                <surname>Jung</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Choi</surname>
                <given-names>HJ</given-names>
              </name>
              <name>
                <surname>Shim</surname>
                <given-names>YJ</given-names>
              </name>
            </person-group>
            <article-title>A cross-sectional retrospective study to analyze the underlying causes and clinical characteristics of children with reactive thrombocytosis at a Korean tertiary medical center.</article-title>
            <source>Blood Res</source>
            <year>2018</year>
            <month>Sep</month>
            <volume>53</volume>
            <issue>3</issue>
            <fpage>233</fpage>
            <page-range>233-239</page-range>
            <pub-id pub-id-type="pmid">30310791</pub-id>
          </element-citation>
        </ref>
        <ref id="article-30100.r56">
          <label>56</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Kaser</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Brandacher</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Steurer</surname>
                <given-names>W</given-names>
              </name>
              <name>
                <surname>Kaser</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Offner</surname>
                <given-names>FA</given-names>
              </name>
              <name>
                <surname>Zoller</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Theurl</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Widder</surname>
                <given-names>W</given-names>
              </name>
              <name>
                <surname>Molnar</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Ludwiczek</surname>
                <given-names>O</given-names>
              </name>
              <name>
                <surname>Atkins</surname>
                <given-names>MB</given-names>
              </name>
              <name>
                <surname>Mier</surname>
                <given-names>JW</given-names>
              </name>
              <name>
                <surname>Tilg</surname>
                <given-names>H</given-names>
              </name>
            </person-group>
            <article-title>Interleukin-6 stimulates thrombopoiesis through thrombopoietin: role in inflammatory thrombocytosis.</article-title>
            <source>Blood</source>
            <year>2001</year>
            <month>Nov</month>
            <day>01</day>
            <volume>98</volume>
            <issue>9</issue>
            <fpage>2720</fpage>
            <page-range>2720-5</page-range>
            <pub-id pub-id-type="pmid">11675343</pub-id>
          </element-citation>
        </ref>
        <ref id="article-30100.r57">
          <label>57</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Senchenkova</surname>
                <given-names>EY</given-names>
              </name>
              <name>
                <surname>Komoto</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Russell</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Almeida-Paula</surname>
                <given-names>LD</given-names>
              </name>
              <name>
                <surname>Yan</surname>
                <given-names>LS</given-names>
              </name>
              <name>
                <surname>Zhang</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Granger</surname>
                <given-names>DN</given-names>
              </name>
            </person-group>
            <article-title>Interleukin-6 mediates the platelet abnormalities and thrombogenesis associated with experimental colitis.</article-title>
            <source>Am J Pathol</source>
            <year>2013</year>
            <month>Jul</month>
            <volume>183</volume>
            <issue>1</issue>
            <fpage>173</fpage>
            <page-range>173-81</page-range>
            <pub-id pub-id-type="pmid">23673000</pub-id>
          </element-citation>
        </ref>
        <ref id="article-30100.r58">
          <label>58</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Schafer</surname>
                <given-names>AI</given-names>
              </name>
            </person-group>
            <article-title>Thrombocytosis.</article-title>
            <source>N Engl J Med</source>
            <year>2004</year>
            <month>Mar</month>
            <day>18</day>
            <volume>350</volume>
            <issue>12</issue>
            <fpage>1211</fpage>
            <page-range>1211-9</page-range>
            <pub-id pub-id-type="pmid">15028825</pub-id>
          </element-citation>
        </ref>
        <ref id="article-30100.r59">
          <label>59</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Araneda</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Krishnan</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Hall</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Kalbfleisch</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Krishnaswamy</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Krishnan</surname>
                <given-names>K</given-names>
              </name>
            </person-group>
            <article-title>Reactive and clonal thrombocytosis: proinflammatory and hematopoietic cytokines and acute phase proteins.</article-title>
            <source>South Med J</source>
            <year>2001</year>
            <month>Apr</month>
            <volume>94</volume>
            <issue>4</issue>
            <fpage>417</fpage>
            <page-range>417-20</page-range>
            <pub-id pub-id-type="pmid">11332909</pub-id>
          </element-citation>
        </ref>
        <ref id="article-30100.r60">
          <label>60</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Scharf</surname>
                <given-names>RE</given-names>
              </name>
            </person-group>
            <article-title>Do we need antiplatelet therapy in thrombocytosis? Contra. Proposal for an individualized risk-adapted treatment.</article-title>
            <source>Hamostaseologie</source>
            <year>2016</year>
            <month>Nov</month>
            <day>07</day>
            <volume>36</volume>
            <issue>4</issue>
            <fpage>241</fpage>
            <page-range>241-260</page-range>
            <pub-id pub-id-type="pmid">27414763</pub-id>
          </element-citation>
        </ref>
        <ref id="article-30100.r61">
          <label>61</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Kulnigg-Dabsch</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Schmid</surname>
                <given-names>W</given-names>
              </name>
              <name>
                <surname>Howaldt</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Stein</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Mickisch</surname>
                <given-names>O</given-names>
              </name>
              <name>
                <surname>Waldh&#x000f6;r</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Evstatiev</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Kamali</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Volf</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Gasche</surname>
                <given-names>C</given-names>
              </name>
            </person-group>
            <article-title>Iron deficiency generates secondary thrombocytosis and platelet activation in IBD: the randomized, controlled thromboVIT trial.</article-title>
            <source>Inflamm Bowel Dis</source>
            <year>2013</year>
            <month>Jul</month>
            <volume>19</volume>
            <issue>8</issue>
            <fpage>1609</fpage>
            <page-range>1609-16</page-range>
            <pub-id pub-id-type="pmid">23644823</pub-id>
          </element-citation>
        </ref>
        <ref id="article-30100.r62">
          <label>62</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Jimenez</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Kulnigg-Dabsch</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Gasche</surname>
                <given-names>C</given-names>
              </name>
            </person-group>
            <article-title>Management of Iron Deficiency Anemia.</article-title>
            <source>Gastroenterol Hepatol (N Y)</source>
            <year>2015</year>
            <month>Apr</month>
            <volume>11</volume>
            <issue>4</issue>
            <fpage>241</fpage>
            <page-range>241-50</page-range>
            <pub-id pub-id-type="pmid">27099596</pub-id>
          </element-citation>
        </ref>
        <ref id="article-30100.r63">
          <label>63</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Alberio</surname>
                <given-names>L</given-names>
              </name>
            </person-group>
            <article-title>Do we need antiplatelet therapy in thrombocytosis? Pro. Diagnostic and pathophysiologic considerations for a treatment choice.</article-title>
            <source>Hamostaseologie</source>
            <year>2016</year>
            <month>Nov</month>
            <day>07</day>
            <volume>36</volume>
            <issue>4</issue>
            <fpage>227</fpage>
            <page-range>227-240</page-range>
            <pub-id pub-id-type="pmid">25707870</pub-id>
          </element-citation>
        </ref>
        <ref id="article-30100.r64">
          <label>64</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Almanaseer</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Chin-Yee</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Ho</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Lazo-Langner</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Schenkel</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Bhai</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Sadikovic</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Chin-Yee</surname>
                <given-names>IH</given-names>
              </name>
              <name>
                <surname>Hsia</surname>
                <given-names>CC</given-names>
              </name>
            </person-group>
            <article-title>An Approach to the Investigation of Thrombocytosis: Differentiating between Essential Thrombocythemia and Secondary Thrombocytosis.</article-title>
            <source>Adv Hematol</source>
            <year>2024</year>
            <volume>2024</volume>
            <fpage>3056216</fpage>
            <pub-id pub-id-type="pmid">38375212</pub-id>
          </element-citation>
        </ref>
        <ref id="article-30100.r65">
          <label>65</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Purohit</surname>
                <given-names>AHL</given-names>
              </name>
              <name>
                <surname>Bharti</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Kumar</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Bohra</surname>
                <given-names>GK</given-names>
              </name>
              <name>
                <surname>Khichar</surname>
                <given-names>S</given-names>
              </name>
            </person-group>
            <article-title>Pseudothrombocytosis in Case of Betathalassaemia Intermedia Masquerading as Myeloproliferative Neoplasm.</article-title>
            <source>Curr Med Imaging</source>
            <year>2021</year>
            <volume>17</volume>
            <issue>10</issue>
            <fpage>1177</fpage>
            <page-range>1177-1178</page-range>
            <pub-id pub-id-type="pmid">33719977</pub-id>
          </element-citation>
        </ref>
        <ref id="article-30100.r66">
          <label>66</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Zhu</surname>
                <given-names>Q</given-names>
              </name>
              <name>
                <surname>Zhang</surname>
                <given-names>Z</given-names>
              </name>
              <name>
                <surname>Zhang</surname>
                <given-names>L</given-names>
              </name>
            </person-group>
            <article-title>Pseudothrombocytosis Associated with Heatstroke.</article-title>
            <source>Clin Lab</source>
            <year>2024</year>
            <month>Feb</month>
            <day>01</day>
            <volume>70</volume>
            <issue>2</issue>
            <pub-id pub-id-type="pmid">38345993</pub-id>
          </element-citation>
        </ref>
        <ref id="article-30100.r67">
          <label>67</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Ni</surname>
                <given-names>SC</given-names>
              </name>
              <name>
                <surname>Lin</surname>
                <given-names>CC</given-names>
              </name>
            </person-group>
            <article-title>Pseudothrombocytosis in Acute Myeloid Leukaemia.</article-title>
            <source>Br J Haematol</source>
            <year>2023</year>
            <month>Aug</month>
            <volume>202</volume>
            <issue>3</issue>
            <fpage>456</fpage>
            <pub-id pub-id-type="pmid">37153971</pub-id>
          </element-citation>
        </ref>
        <ref id="article-30100.r68">
          <label>68</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Larsen</surname>
                <given-names>PB</given-names>
              </name>
              <name>
                <surname>Vikes&#x000e5;</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Friis-Hansen</surname>
                <given-names>L</given-names>
              </name>
            </person-group>
            <article-title>EDTA-induced pseudothrombocytosis and citrate-induced platelet agglutination in a patient with Waldenstrom macroglobulinemia.</article-title>
            <source>Clin Case Rep</source>
            <year>2017</year>
            <month>Aug</month>
            <volume>5</volume>
            <issue>8</issue>
            <fpage>1243</fpage>
            <page-range>1243-1247</page-range>
            <pub-id pub-id-type="pmid">28781833</pub-id>
          </element-citation>
        </ref>
        <ref id="article-30100.r69">
          <label>69</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Sasaki</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Kawai</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Tsuno</surname>
                <given-names>NH</given-names>
              </name>
              <name>
                <surname>Sunami</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Kitayama</surname>
                <given-names>J</given-names>
              </name>
            </person-group>
            <article-title>Impact of preoperative thrombocytosis on the survival of patients with primary colorectal cancer.</article-title>
            <source>World J Surg</source>
            <year>2012</year>
            <month>Jan</month>
            <volume>36</volume>
            <issue>1</issue>
            <fpage>192</fpage>
            <page-range>192-200</page-range>
            <pub-id pub-id-type="pmid">22045447</pub-id>
          </element-citation>
        </ref>
        <ref id="article-30100.r70">
          <label>70</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Su</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Hou</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Zhao</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Li</surname>
                <given-names>Y</given-names>
              </name>
            </person-group>
            <article-title>Secondary thrombocythemia with ST-segment elevation myocardial infarction as the first manifestation: a case report.</article-title>
            <source>Ann Med Surg (Lond)</source>
            <year>2023</year>
            <month>Aug</month>
            <volume>85</volume>
            <issue>8</issue>
            <fpage>4145</fpage>
            <page-range>4145-4149</page-range>
            <pub-id pub-id-type="pmid">37554887</pub-id>
          </element-citation>
        </ref>
        <ref id="article-30100.r71">
          <label>71</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Aboujabal</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Sadek</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Obaid</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Sawaf</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Habas</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Habib</surname>
                <given-names>MB</given-names>
              </name>
            </person-group>
            <article-title>Iron deficiency-induced thrombocytosis presenting with blue toe syndrome.</article-title>
            <source>Clin Case Rep</source>
            <year>2024</year>
            <month>Apr</month>
            <volume>12</volume>
            <issue>4</issue>
            <fpage>e8596</fpage>
            <pub-id pub-id-type="pmid">38571904</pub-id>
          </element-citation>
        </ref>
      </ref-list>
    </back>
  </book-part>
</book-part-wrapper>
